https://www.avient.com/sites/default/files/2020-12/firecon-cpe-a-processing-guide-spanish-1.pdf
EXTRUSOR
Tornillo Tornillo de regulación de rosca profunda de 1" a 6"
Relación de compresión 3:1
Cabezal De tubo: sin hilera (para tamaños pequeños)
De presión: para tamaños de 1" o superiores
Dado De tubo: bajo coeficiente de estirado
De presión: hilera corta
L/D 24:1 o superior
Paquete de mallas Malla de 20/40/20
Canal de enfriamiento 50–65°C recomendado
Secador Aire caliente o desecante, 4 horas a 79–85°C
PROCESAMIENTO
Temperatura
Precalentamiento del alambre Ninguno
Zonas de alimentación 143–149°C
Transición 160–171°C
Dosificación 171–176°C
Cabezal/dado 176–185°C
Material fundido 176–185°C
Fusión máxima 199°C
Compuesto de purga HDPE
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2020-09/versaflex-pf-final.pdf
VersaflexTM PF
Versaflex PF
VOC
VERSAFLEX PF
VOC
39 LDPE / 13 Versaflex PF
VERSAFLEX PF
39 LDPE / 13 Versaflex PF
N
/2
5
N
/2
5
F = 25 ° C 7 I = 25 ° C 20
MD6741 / MD6700
VERSAFLEX PFTM
+86 021 60284888
www.avient.com
VERSAFLEX™ PF
1 CF6751 PP
2 2420K LDPE
Versaflex™ PF
MD6727
Versaflex™ PF
MD6741
Versaflex™ CF
6751
Versaflex™ PF
MD6649
Versaflex™ PF
9512
Versaflex™ CF
8888N-A
Versaflex™ PF
MD6666
Versaflex™ PF
MD6748
Versaflex™ PF
MD6700
Versaflex™ CF
9000
PP
PVC
Tg (°C) -26 -43 -30 -26 -5 1 -6 0 5 /
(Shore A) 50 49 35 37 38 35 37 31 30 19
MFI (190°C, 2.16kg)
(g/10min)
/ / / 15 5 15 20 3 5 27
MFI (230°C, 2.16kg) 8 20 8 / / / / / / /
1 LDPE 2420k2/LDPE 2420k/Versaflex™ =4.5/4.5/1 ; =50um
(N/25mm)
25°C 20 1.3 1.8 7.9 2.5 2.2 2.7 3.3 3.0 3.7 4.3
75°C 7 5.7 2.9 7.2 3.1 4.0 4.3 4.3 5.5 5.6 /
PMMA
(N/25mm)
25°C 20 1.8 2.0 7.2 2.6 2.8 3.0 3.6 3.3 3.9 4.9
75°C 7 5.5 4.7 7.1 3.5 / 4.7 6.5 5.8 6.9 /
https://www.avient.com/sites/default/files/2020-08/stan-tone-wdn-product-bulletin.pdf
%
Solids
Color
Index
pH
Typical
Weight
Lbs/Gal
WHITE
10WDN03
Titanium Dioxide,
Rutile
60 73 PW-6 9 16.7
YELLOW
12WDN01 Diarylide AAOT GS 35 43 PY-14 8.8 9.4
12WDN02 Diarylide HR RS 37 44 PY-83 8.8 9.6
12WDN03 Arylide GY RS 38 45 PY-74 8.8 9.2
81WDN01 Iron Oxide 55 63 PY-42 8.8 14.5
ORANGE
15WDN01 Pryazolone YS 40 45 PO-13 8.8 9.2
15WDN03 Dianisidine RS 35 37 PO-16 8.8 9.2
15WDN06 DNA Orange RS 31 43 PO-5 8.8 9.7
RED
22WDN01 Lithol Rubine BS 33 40 PR-57 8.8 9.8
21WDN01 Naphthol BS 35 43 N/A 8.8 9.5
25WDN01 Red 2B, Ca BS 34 41 PR-48:2 8.8 9.6
28WDN01 Red 2B, Ba YS 36 44 PR-48:1 8.8 9.5
82WDN02 Iron Oxide 57 66 PR-101 8.8 16
BLUE
40WDN01 Phthalocyanine RS 35 46 PB-15 8.8 9.7
40WDN03 Phthalocyanine GS 38 43 PB-15:3 8.8 9.8
GREEN
WDN-27822 Phthalocyanine BS 42 53 PG-7 8.8 10.5
VIOLET/MAGENTA
24WDN02 Carbazole 35 48 PV-23 8.8 9.6
24WDN03 Quinacridone 31 39 PV-19 8.8 9.6
24WDN05 Quinacridone 30 41 PR-122 8.8 10
BLACK
90WDN01 Carbon Black 45 49 PB-7 8.8 9.3
WDN
RS = Red Shade YS = Yellow Shade BS = Blue Shade GS = Green Shade HR = Heat-Resistant
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2022-12/Mevopur Colors for Ophthalmic Closures Application Bulletin_A4.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified
manufacturing sites, providing global
consistency and increased security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without animal-
derived substances
• Standard concentrates in a PE carrier and
on request in PP
• Pre-colored formulations can be supplied in
specific resins selected for the application
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III)
• Food contact established with FDA/EU*
APPLICATION BULLETIN
DRUG TYPE COLOR
DESCRIPTION
PANTONE
REFERENCE
AVIENT PRODUCT
CODE PE BASED
Adrenergic agonist
combinations Light Green 373 C PE6M176349
Adrenergic agonists Purple 2583 C PE4M176057
Anti-infectives Tan 467 C PE8M176130
Anti-inflammatory,
nonsteroidal Grey Cool Grey 4 C PE7M176184
steroids Pink 197 C PE3M176237
Anti-inflammatory,
immunomodulators Olive Green 5763 C On request
Beta-blockers Yellow Yellow C PE1M176160
Beta-blocker combinations Dark Blue 281 C PE5M176272
Carbonic anhydrase inhibitors Orange 1585 C PE2M176089
Cytotoxic Black 6 C PL9M176008
Miotics Dark Green 348 C PE6M176267
Mydriatics and cycloplegics Red 1797 C PE3M176236
Prostaglandin analogues Turquoise 326 C PE5M176273
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2021-11/avient-th.-bergmann-gmbh-cr-extract-nov-8-2021.pdf
Änderungsbeschluss:
Sonderband
Blatt 101 ff.
2 b)
Ximena, Philippe, Lyon (Frankreich),
*18.11.1960
Setzen, Marc, Baden-Baden, *27.05.1969
05.02.2007
Seite 2 von 4
3 b)
Adolf-Dambach-Str. 2, 76571 Gaggenau
Tomaselli, Frank, La Wantzenau/Frankreich,
*28.12.1963
Ximena, Philippe, Lyon (Frankreich),
*18.11.1960
23.04.2009
4 b)
Mohn, Christopher, Lasne/Belgien, *11.06.1955
10.01.2011
5 b)
Neue
Adolf-Dambach-Str.4, 76571 Gaggenau
Kronimus, Holger, Hilgert, *26.01.1968
Baert, Bernard, Verviers/Belgien, *18.12.1949
Tomaselli, Frank, La Wantzenau/Frankreich,
*28.12.1963
15.02.2012
6 b)
Der zwischen der Gesellschaft und der nunmehr infolge
Firmenänderung und Sitzverlegung "PolyOne Deutschland
GmbH", Bendorf (Amtsgericht Koblenz HRB 7522) am
03.11.2014
Seite 3 von 4
13.12.1994 abgeschlossene Beherrschungs- und
Ergebnisabführungsvertrag wurde neugefasst und besteht
nunmehr als Gewinnabführungsvertrag fort.Die
Gesellschafterversammlungen haben der Neufassung am
20.10.2014 zugestimmt.
https://www.avient.com/sites/default/files/2024-10/Avient CDP Climate Change %26 Water Submission 20241001.pdf
6
Are you able to provide geolocation data for
your facilities?
For example, the Edgetek PKE series consists of specialty engineered polyketone (PK)
59
thermoplastics designed to offer manufacturers a high-performing, cost-competitive, and eco-conscious alternative to traditional nylons (PA66 and PA6).
This serves as a formal way
for stockholders to influence the company’s strategy. 6.
https://www.avient.com/sites/default/files/2021-02/avient-ir-presentation-goldman-sachs-and-morgan-stanley.pdf
Q 4 AN D FU LL Y EA R
2020 PE RF O RM AN CE
$0.30
$0.52
Q4 2020 ORGANIC PERFORMANCE
Sales
$922
$997
+8%
Operating
Income
EPS
$58
$80
+38%
+73%
• Record 4th quarter sales, adjusted
operating income and adjusted EPS
performance
• All segments delivered year-over-year
sales and operating income growth, led
by consumer and healthcare end markets
• Clariant Masterbatch integration synergy
capture ahead of schedule: $5 million
realized in 2020
($ in millions except EPS)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
Q4 2020 SEGMENT PERFORMANCE
10
Sales Operating Income
$100 $100 $100
$922
$100 $100 $100
$997
Distribution CAI SEM Total
2019 2020
$178
$272
$490
$191
$305
$526
SEM Distribution CAI
+8%
+7%
+7%
+12%
$5 $5 $5
$58
$5 $5 $5
$80
Avient CAI SEM Total
$17 $19
$40
$18
$30
$58
Distribution SEM CAI
+38%
+45%
+58%
+6%
(3) (3)
(1) (2)
(1) Total company sales include intercompany sales eliminations
(2) Total company reflects adjusted operating income and includes corporate costs
(3) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
2020 HIGHLIGHTS
11
• Completed transformational Clariant Masterbatch acquisition and created new
brand name Avient
• Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier
during the pandemic and due to growth in demand for consumer applications
• Specialty Engineered Materials delivered record operating income on gains from
composites
• Achieved record free cash flow, increased dividend for 10th year in a row and
delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA
• Culture is everything: Certified as a Great Place to Work®
$133
$150
23%8%
21%
2006 2020PF
Avient Portfolio Transformation
22%
59%
CLARIANT MASTERBATCH:
TRANSFORMATIONAL ACQUISITION
12
Clariant MB EBITDA Growth
Purchase Price Multiple
10.8
9.6
6.5
2019PF 2020PF 2020PF w/ Full
Synergies
• Acquisition of Clariant Masterbatch
significantly expands presence in
healthcare, packaging and consumer end
markets
• Strength of portfolio – 13% EBITDA growth
as an essential supplier in COVID response
and recovery
• Acquisition completed on July 1, 2020 for
$1.4 billion.
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
25
Capex / Revenue
2021E (%)
AVIENT IS ASSET LIGHT
Avient Specialty
Other
2 3 2 2 2 3 3
3 4 4 5 5 5 6 6 6 7
25
t
(E
xc
l.
https://www.avient.com/sites/default/files/2023-07/Avient-2022-Sustainability-Report.pdf
North Haven, Connecticut Pune, India(a)
6.
Alicante, Spain 6.
Minority 17%
White 83%
Age
30–50 17%
Over 50 83%
Global Gender Diversity by Level—Female
Directors, General Managers, VP/SVP 19%
Management 30%
Professionals 38%
Production Associates 6%
All Avient Associates 21%
* U.S.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Credit%2520Suisse%2520-%2520June%25202015.pdf
PolyOne Corporation Page 4
PolyOne Commodity to Specialty Transformation
• Volume driven,
commodity producer
• Heavily tied to
cyclical end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2014 2015 and beyond
• Steve Newlin
appointed, Chairman,
President and CEO
• New leadership team
appointed
• Implementation of four
pillar strategy
• Focus on value based
selling, investment in
commercial resources
and innovation to drive
transformation
• Substantial EPS growth
from $0.13 to all-time
high of $1.80
• Shift to faster growing,
high margin, less
cyclical end markets
• Key acquisitions propel
current and future
growth, as well as
margin expansion
• Specialty mix expands
to 65% of Operating
Income – strongest mix
of earnings in history
• Accelerating growth
• Deliver consistent
double digit annual
EPS growth
• Maintain >35% vitality
index
• Pursue strategic
acquisitions that
expand specialty
offerings and
geographic breadth
• Invest and grow
current and next
generation talent
PolyOne Corporation Page 5
Building &
10%
Electrical &
11%
9%
Distribution
28%
PP&S
52%
69%
13%
7% Asia
2014 Revenues: $3.8 Billion
End Markets
2014 Revenues: $3.8 Billion
PolyOne
At A Glance
$13
$31
$46 $46
$87 $96
$122
$195
$242
2006 2007 2008 2009 2010 2011 2012 2013 2014
Specialty Operating Income ($M)
PolyOne Corporation Page 6
Old
PolyOne
*Operating Income excludes corporate charges and special items
2%
34% 43%
62%
65%
69%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2014 Q1 2015 2020
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
80%+
Specialty OI $5M $46M $87M $195M $242M $60M
Mix Shift Highlights Specialty Transformation
Transformation
2020
Platinum
Vision
Platinum
Vision
PolyOne Corporation Page 7
Confirmation of Our Strategy
The World’s Premier Provider of Specialized
Polymer Materials, Services and Solutions
Specialization Globalization
Operational
Excellence
Commercial
Excellence
PolyOne Corporation Page 8
-100%
0%
200%
300%
400%
500%
600%
Strategy and Execution Drive Results
$0.12
$0.27
$0.21
$0.13
$0.68
$0.82
$1.00
$1.31
$1.80
'06 '07 '08 '09 '10 '11 '12 '13 '14
‘06-‘14 Adjusted EPS CAGR = 40%
Adjusted EPS Share Price vs.
S&P 500
PolyOne Corporation Page 9
2006 Q1 2015 2020
“Where we were” “Where we are” Platinum Vision
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 16.2% 20%+
Global Specialty Engineered
Materials 1.1% 16.3% 20%+
Designed Structures & Solutions 1.4% (2012) 2.7% 12 – 14%
Performance Products &
Solutions 5.5% 6.5% 10 – 12%
Distribution 2.6% 5.9% 6.5 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 69% 80%+
3) ROIC 5.0% 11.4% 15%
4) Adjusted EPS Growth N/A
22 Consecutive
Quarters of
EPS Growth
Double Digit
Expansion
Proof of Performance & 2020 Goals
PolyOne Corporation Page 10
Platinum Vision: Pathway to Accelerated Growth
Organic
Sales Growth
Margin
Expansion
Share
Repurchases
Acquisitions
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 12
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 13
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
6
9
7
3
5
12
5 3 2
8
4
2
4
3
1
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 14 8 18 12 22 74
Addressable Market
($ millions) $700 $600 $600 $1,900
PolyOne Corporation Page 14
60%
98%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 Q1 2015
Pension Funding**
As of March 31, 2015
Debt Maturities & Pension Funding
Net Debt / EBITDA* = 2.1x
$49
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2015
($ millions)
Coupon Rate: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2015
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
~75% of capital
expenditures fund
growth initiatives Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
Synergy opportunities
Adjacent material
solutions
Repurchased over
500k shares in Q1
2015
Repurchased 11.8
million shares since
early 2013
8.2 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Platform
operating
income
mix
percentage 2005* 2006* 2007* 2008* 2009* 2010* 2011 2012 2013 2014 2015 Q1
Global Color,
Additives and
Inks
$ 4.3 $ 8.9 $ 25.7 $ 28.1 $ 25.2 $ 37.7 $ 50.2 $ 75.3 $ 104.0 $ 124.9 $ 33.8
Global
Engineered
Materials
0.4 3.9 4.9 17.6 20.6 49.7 45.9 47.0 57.2 72.4 23.1
Designed
Structures and
- - - - - - - - 33.4 45.1 3.2
Platform $ 4.7 $ 12.8 $ 30.6 $ 45.7 $ 45.8 $ 87.4 $ 96.1 $ 122.3 $ 194.6 $ 242.4 $ 60.1
Performance
Products and
75.7 64.2 65.8 31.3 33.1 54.0 27.7 38.8 56.0 63.1 11.5
Distribution 19.5 19.2 22.1 28.1 24.8 42.0 56.0 66.0 63.3 68.2 15.7
Joint ventures 91.9 102.9 34.8 28.6 25.5 18.9 5.0 - - - -
Corporate and
eliminations (51.5) 34.5 (73.3) (425.1) 7.9 (27.7) 18.2 (89.6) (82.4) (218.6) (17.2)
Operating
income (loss)
GAAP
$ 140.3 $ 233.6 $ 80.0 $ (291.4) $ 137.1 $ 174.6 $ 203.0 $ 137.5 $ 231.5 $ 155.1 $ 70.1
Less:
Corporate
operating
expense
51.5 (34.5) 73.3 425.1 (7.9) 27.7 (18.2) 89.6 82.4 218.6 17.2
Operating
income
excluding
Corporate
$ 191.8 $ 199.1 $ 153.3 $ 133.7 $ 129.2 $ 202.3 $ 184.8 $ 227.1 $ 313.9 $ 373.7 $ 87.3
platform
operating mix
percentage
2% 6% 20% 34% 35% 43% 52% 54% 62% 65% 69%
* Historical results have not been restated for the Resin business divestiture or the related resegmentation.
https://www.avient.com/sites/default/files/2020-03/Global_High_Yield_%26_Leverage_Conference %281%29.pdf
V I S I O N
PolyOne Corporation 4
To be the world’s
premier provider of
specialized polymer
materials, services and
solutions
C O R E
V A L U E S
P E R S O N A L
V A L U E S
Honesty IntegrityRespect
Operational
Commercial
Specialization
Globalization
Collaboration ExcellenceInnovation
To be the world’s
premier provider of
specialized polymer
materials, services
and solutions
S A F E T Y F I R S T
PolyOne Corporation 5
Injuries per 100 Workers
Spartech
Acquisition
1.3
1.1 1.1
0.85
0.65
0.57
0.54
0.97
0.84
0.74 0.74
0.69
0.51
0.56
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
C O M M O D I T Y T O S P E C I A L T Y T R A N S F O R M A T I O N
PolyOne Corporation 6
• Volume driven,
commodity
production
• Heavily tied to cyclical
end markets
• Performance largely
dependent on non-
controlling joint
ventures
• Shift to value-based
selling & an innovative
culture
• New leadership team
appointed
• Implementation of
four pillar strategy
• Investment in
commercial training
and innovation
• Faster growing, high
margin focus
• Accelerated growth
with world class
vitality index
• Significant
commercial resource
additions
• Expanded margins
with specialty focus
• Acquired strategic,
bolt-on companies to
expand technology
offerings and improve
geographic breadth
Volume Value Transformation The Future
2006 - 2013 2013 – 20192000-2005 2006 - 2013
• Landmark portfolio
transformation
creates specialty
growth company
• Sustainability / mega-
trends drive above
market growth
2020 and
Beyond
PolyOne Corporation 7
P O L Y O N E
2 0 1 9 R E V E N U E | $ 2 . 9 B I L L I O N
Segment End Market Geography
15% Healthcare
Wire & Cable
Building &
Electrical &
Electronics
Color
Additives
& Inks
34%
Distribution
41%
Specialty
Engineered
25%
54%
Latin
America
P R O O F O F P E RFO RMAN CE
C O N S E C U T I V E
Y E A R S
10
A D J U S T E D E P S E X P A N S I O N
PolyOne Corporation 8
$1.69
$1.51
S U S T A I N A B L E P A T H T O D O U B L E - D I G I T E P S G R O W T H
PolyOne Corporation 9
P E O P L E P R O D U C T S P L A N E T P E R F O R M A N C E
Double digit
annual EPS
growth
Expand specialty portfolio
with strategic acquisitions
Innovate and develop new
technologies and services
Repurchase 600K-1M
shares annually
Increase commercial
resources 5-7% annually
Double acquired
company margins
Enhance efficiencies
through Lean Six Sigma
and commercial excellence
531
710
1,042
130
164
208
504
663
880
2014 2018 2019E PF*
R&D / Technical Marketing Sales
PolyOne Corporation 10
+ 34%
+ 26%
+ 32%
E X P A N S I O N O F COMMERCIAL RESOURCES D R I V I N G G R O W T H
$2.9 $2.9
$3.5
2015 2016 2017 2018 2019E
PF
Total
+ 9%
Organic
+ 5%
Revenue in Billions
Total
+ 10%
Organic
+ 7%+ 47%
+ 27%
+ 33%
$4.0
$3.2
2019E PF*
Lead
Specialists
T H E E V O L V I N G C U S T O M E R R E L A T I O N S H I P
PolyOne Corporation 11
Expanded Path
Traditional Path
Strategic Accounts/
Field Sales
Business
Development
Customer
Service
Web and Social
Media
Inside Sales
PolyOne Corporation 12
Investments in digital and dedicated inside sales to
improve customer experience
110% increase in leads (from 6,000 to 12,700) driven
by website, phone, and online chat
EXPANDED PATH
A D D I N G C U S T O M E R T O U C H P O I N T S
4
33
Inside sellers
$11M
$87M
Inside sales/digital revenue
A L I G N I N G W I T H T R E N D S F O R G R O W T H
T R A N S P O R T A T I O N P A C K A G I N G H E A L T H C A R E C O N S U M E R
PolyOne Corporation 13
Facilitate
alternative
energy
solutions
Light-
weighting
Reduce
packaging
materials
Improve
recyclability
Reduce
spread of
infection
R E V E N U E F R O M S U S T A I N A B L E S O L U T I O N S
PolyOne Corporation 14
2016 2017 2018 2019
Lightweighting Reduced Material Requirements Improved Recyclability
Renewable Energy Applications Eco-conscious Bio-derived Content
Reduced Energy Use VOC Reduction
$275M
$325M
$355M
$410M 14% Total Annual Growth
9% Organic Annual Growth
I N N O V A T I O N
PolyOne Corporation 15
Customization
55%
M&A
Innovation
Pipeline
Innovation comes from Research & Development Spend
($ millions)
Vitality Index
% of sales from products launched last 5 years
37%
2006 2019
$20
$51
2006 2019
Transformational
Opportunity for Growth
Through M&A
Adjacent
Opportunity for
Growth Through New
Product Pipeline
Core
Customization
3 H O R I Z O N S O F D E V E L O P M E N T
PolyOne Corporation 16
Incremental
development
from existing
base of
technology
New development
adjacent to current
New technology
development
outside of and with
our current base
Service adjacent
markets and
Create new
markets, target
new customer
needs
Service existing
markets and
Market
Technical
I N N O V A T I O N
Non-Halogen Flame
Retardants
Barrier Technologies
Fiber Colorants
Advanced Composites
Thermoplastic Elastomers
Gordon Composites/
Polystrand – Composites
GLS – Thermoplastic Elastomers
ColorMatrix – Liquid Color & Additives
PlastiComp
Fiber-Line
I N N O V A T I O N S P O T L I G H T :
C O M P O S I T E S
PolyOne Corporation 17
C O M P O S I T E M A T E R I A L S
Glass
Carbon Aramid
Thermosets
Thermoplastics
PolymersFibers
PolyOne Corporation 18
Focused End Markets
• Wire & Cable / Electrical
• Consumer
• Transportation
• Industrial
C O M P O S I T E S P O R T F O L I O
D I V E R S E C A P A B I L I T I E S A N D S O L U T I O N S S E R V I N G
M A N U F A C T U R E R S A N D O E M S
PolyOne Corporation 19
LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers
P O L Y O N E A P P L I C A T I O N S I N F I B E R O P T I C C A B L E S
PolyOne Corporation 20
1.
Outer strength member
• Base fiber of Kevlar, E-Glass, Zylon, Vectran LCP
• Often be coated with Fiber-Line coatings (Swellcoat,
Bondcoat, Wearcoat)
6.
Binder
• PET, Polyester, Kevlar yarns coated with Swellcoat
(absorbs and blocks water)
2 3 4
5
7
6
8
9.